SAT Health offers HTA analysis to provide a bridge between the world of research and the world of decision-making. The importance of HTA analysis and consulting for supporting management, clinical and policy decisions is growing internationally. Opportunity costs from making wrong decisions continue to grow. Understanding the importance of HTA and precise health policy decisions is becoming more significant for the business sustainability.
We aim to provide our customers with professional assessment, conducted by interdisciplinary groups using explicit analytical frameworks, drawing on clinical, epidemiological, health economic and other information and methodologies.
SAT Health would like to support your business development in a professional and competent way by offering consulting and wide range of analysis based on our knowledge, experience in the pharmaceutical sector and international network:
- Health Technology Assessment: drugs, medical devices, and diagnostic methods - Assessment of technical characteristics, safety, clinical efficacy, and real-life effectiveness, costs, social, legal and ethical consequences of the health technologies
- Health policy advisory
- Management consulting
- Investment consulting
- Market access strategy